DocMorris AGXSWX:DOCM +0.06%65 EBIT per Share is CHF-3.29 as of Jun. 2025. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.53 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 532 Healthcare Providers & Services companies, DocMorris AG ranks better than 67.29% on this metric.
DocMorris AG's EBIT per Share for the
six
months ended in Jun. 2025 was CHF-1.03.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2025 was CHF-3.29.
During the past 3 years, the average EBIT per Share Growth Rate was 24.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 3.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for DocMorris AG's EBIT per Share or its related term are showing as below:
XSWX:DOCM'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -65 Med: 3.2 Max: 50.5
Current: 24.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of DocMorris AG was 50.50% per year. The lowest was -65.00% per year. And the median was 3.20% per year.
XSWX:DOCM's 3-Year EBIT Growth Rate is ranked better than 67.29% of 532
companies
in the Healthcare Providers & Services industry
Industry Median: 11.75
vs XSWX:DOCM: 24.20
DocMorris AG's EBIT for the
six
months ended in Jun. 2025 was CHF-50 Mil.
DocMorris AG (XSWX:DOCM) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
DocMorris AG EBIT per Share Related Terms
DocMorris AG EBIT per Share Historical Data
* Premium members only.
The historical data trend for DocMorris AG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-3.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (XSWX:DOCM) has a EBIT per Share of CHF-3.29 as of Jun. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on DocMorris AG and its competitors. According to the industry distribution chart, DocMorris AG ranks #174 out of 532 companies in the Healthcare Providers & Services industry, placing it in the top 32.7%.
Is DocMorris AG's EBIT per Share too high?
DocMorris AG's current EBIT per Share is CHF-3.29. Based on the distribution chart, DocMorris AG ranks #174 out of 532 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's EBIT per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #174 out of 532 companies for EBIT per Share. This puts DocMorris AG in the upper half of its industry. The industry median EBIT per Share is 11.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.75, based on 532 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on DocMorris AG and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current EBIT per Share is CHF-3.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.53, compared to a current price of CHF7.92 — trading 24.8% below its estimated fair value. The current EBIT per Share is CHF-3.29. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current EBIT per Share is CHF-3.29 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF7.92 is trading 24.8% below its estimated GF Value™ of CHF10.53.
GuruFocus considers DocMorris AG to be Modestly Undervalued.
Key valuation signals for XSWX:DOCM:
EBIT per Share: CHF-3.29
GF Value™: CHF10.53 vs. price of CHF7.92 (24.8% below fair value)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
